For biotech companies embarking on clinical trial planning and execution, finding a CRO to help anticipate and navigate the operational complexities of CAGT therapies is critical. IQVIA Biotech’s multidisciplinary Cell and Gene Therapy Study Management team provides end-to-end solutions to streamline your processes and advance your CAGT clinical trial. Discover more. https://bit.ly/3BVi9Ll #CAGT #clinicaltrials
IQVIA Biotech
Biotechnology Research
Durham, NC 119,908 followers
Supporting biotech companies from innovation to patient impact
About us
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25 years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale.
- Website
-
https://iqviabiotech.com
External link for IQVIA Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Durham, NC
- Founded
- 1998
Updates
-
Over the past 25 years, IQVIA Biotech has been successfully delivering dermatology clinical trials around the world. With board-certified dermatologists on staff, local regulatory expertise, and accelerated patient recruitment, learn how we’re driving new discoveries in dermatology. https://bit.ly/4a65ke4 #dermatology #clinicaltrials
-
-
IQVIA Biotech has been supporting the visionaries, listening to the innovators, and enhancing the capabilities of researchers for more than two decades. From founding in 1998, to rebranding as IQVIA Biotech in 2019, our commitment to help companies maximize patient impact has never wavered. Learn more about our history, and the values we still hold strong. https://bit.ly/4a3w7Yi #clinicalresearch #patientimpact
-
-
The shift to the EU Clinical Trials Regulation (EU CTR) is here, and it’s transforming how active trials are managed. But what does that mean for sponsors and sites? In this Contract Pharma article, Chris Bamford and Shirley Rutter take a deep dive into key considerations for a seamless transition. Whether you're already mid-trial or preparing for upcoming changes, don’t let the transition slow you down… https://bit.ly/3PklmaA #clinicaltrials
-
-
With 500 oncology clinical trials for biotech customers in the last 5 years, IQVIA Biotech has the oncology expertise you need across cell and gene therapies, biologics and small molecules. Discover how our full-service clinical development solutions can advance your oncology breakthrough. https://bit.ly/4fzNgde #oncology #clinicaldevelopment #clinicalresearch #clinicaltrials
-
-
With the FDA poised to require clinically relevant populations for most pivotal trials, a focus on diversity and inclusion is becoming central to study design. This blog post from IQVIA Biotech’s Erin Finot and Kyle Bryan outlines how improved representation in clinical trials can generate more insightful scientific knowledge, and improve access to care for underrepresented patients. Read now. https://bit.ly/4fIi8IB #clinicaltrials #diversity #drugdevelopment
-
-
From sponsors to CROs, we believe that everyone involved in clinical trials has a responsibility to increase access for historically underserved populations. In our insight brief, IQVIA Biotech’s Gerhard Du Toit and IQVIA’s Murray Aitken consider the steps that every stakeholder can take toward improving D&I. Download now. https://bit.ly/3ZUDegV #oncology #clinicaltrials #earlyphaseoncology
-
-
Selene Gardea shares her story about how joining IQVIA Biotech has been one of her best career decisions. "When I received the opportunity to join IQVIA Biotech two years ago, it was very unexpected, I was not looking for a change, but since the first approach I had the feeling this would be a good refresh and a reset for my professional career. I am very grateful to IQVIA Biotech for the confidence in my skills and for considering I would be a good asset for the team. Since the beginning my managers made me feel like part of the company and I received a lot of support from my teammates. The onboarding process was amazing, very helpful and different from the ones I received in my previous jobs. Two years later, I still believe joining IQVIA Biotech has been one of the best decisions I have made in my life. I have grown as a leader, I am still learning from my colleagues and I am proud to belong to this important global company." Join IQVIA's global family: Be a catalyst for positive change in healthcare https://bit.ly/4iUIMkm #Biotech #CareerGrowth #Support #Partnership #WeAreIQVIA #MakingaDifference #Global
-
-
Discover best practices to investigate novel blood cancer therapies with hematology experts Christopher Morley and Sari Heitner Enschede, MD. This insightful white paper explores how biotech companies can address the challenges around investigational agents for hematologic cancers, while considering patient diversity. https://bit.ly/3DzrjxC #hematology #oncology #diversity
-